EVMN · ISSUER CIK 2044725
Evommune, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Evommune, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 15, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 202616:28 | Sep 30, 2026 | EVMN | President & CEO, Director | A · GrantLate 15d | $7.02 | +1,115 | 631,573 | +0% | $8K |